Neville Rodie & Shaw Inc Zoetis Inc. Transaction History

Neville Rodie & Shaw Inc

$1.36 Billion
Q3 2024

A detailed history of Neville Rodie & Shaw Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Neville Rodie & Shaw Inc holds 128,494 shares of ZTS stock, worth $21.2 Million. This represents 1.85% of its overall portfolio holdings.

Number of Shares

128,494

Previous 132,266 2.85%

Holding current value

$21.2 Million

Previous $22.9 Million 9.49%

% of portfolio

1.85%

Previous 1.74%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 01, 2024	SELL	$172.58 - $196.48 $650,971 - $741,122	-3,772 Reduced 2.85%	128,494 $25.1 Million
Q2 2024 Jul 01, 2024	SELL	$145.54 - $178.83 $773,254 - $950,123	-5,313 Reduced 3.86%	132,266 $22.9 Million
Q1 2024 Apr 09, 2024	BUY	$165.67 - $199.94 $482,099 - $581,825	2,910 Added 2.16%	137,579 $23.3 Million
Q4 2023 Jan 02, 2024	SELL	$151.44 - $200.09 $220,648 - $291,531	-1,457 Reduced 1.07%	134,669 $26.6 Million
Q3 2023 Oct 10, 2023	SELL	$167.14 - $192.77 $140,899 - $162,505	-843 Reduced 0.62%	136,126 $23.7 Million
Q2 2023 Jul 06, 2023	BUY	$160.94 - $186.23 $198,439 - $229,621	1,233 Added 0.91%	136,969 $23.6 Million
Q1 2023 Apr 04, 2023	BUY	$145.48 - $175.02 $332,858 - $400,445	2,288 Added 1.71%	135,736 $22.6 Million
Q4 2022 Jan 03, 2023	SELL	$131.14 - $157.47 $320,768 - $385,171	-2,446 Reduced 1.8%	133,448 $19.6 Million
Q3 2022 Oct 04, 2022	SELL	$148.29 - $182.55 $112,700 - $138,738	-760 Reduced 0.56%	135,894 $20.2 Million
Q2 2022 Jul 06, 2022	SELL	$155.97 - $200.09 $71,902 - $92,241	-461 Reduced 0.34%	136,654 $23.5 Million
Q1 2022 Apr 05, 2022	SELL	$181.39 - $234.03 $421,187 - $543,417	-2,322 Reduced 1.67%	137,115 $26.2 Million
Q4 2021 Jan 05, 2022	SELL	$193.69 - $247.03 $443,356 - $565,451	-2,289 Reduced 1.62%	139,437 $34 Million
Q3 2021 Oct 06, 2021	SELL	$189.29 - $209.69 $422,684 - $468,237	-2,233 Reduced 1.55%	141,726 $27.5 Million
Q2 2021 Jul 06, 2021	SELL	$155.9 - $187.99 $109,285 - $131,780	-701 Reduced 0.48%	143,959 $26.8 Million
Q1 2021 Apr 08, 2021	SELL	$144.0 - $169.39 $422,208 - $496,651	-2,932 Reduced 1.99%	144,660 $22.8 Million
Q4 2020 Mar 04, 2021	SELL	$157.07 - $174.35 $1.15 Million - $1.27 Million	-7,299 Reduced 4.71%	147,592 $24.4 Million
Q3 2020 Oct 01, 2020	BUY	$137.1 - $165.37 $179,189 - $216,138	1,307 Added 0.85%	154,891 $25.6 Million
Q2 2020 Jul 15, 2020	BUY	$111.92 - $142.53 $126,805 - $161,486	1,133 Added 0.74%	153,584 $21 Million
Q1 2020 Apr 01, 2020	SELL	$92.66 - $144.94 $88,768 - $138,852	-958 Reduced 0.62%	152,451 $17.9 Million
Q4 2019 Jan 08, 2020	BUY	$116.25 - $133.25 $739,350 - $847,470	6,360 Added 4.33%	153,409 $20.3 Million
Q3 2019 Oct 02, 2019	SELL	$112.57 - $128.43 $321,499 - $366,796	-2,856 Reduced 1.91%	147,049 $18.3 Million
Q2 2019 Jul 01, 2019	SELL	$97.98 - $114.28 $307,951 - $359,182	-3,143 Reduced 2.05%	149,905 $17 Million
Q1 2019 Apr 08, 2019	BUY	$81.56 - $100.67 $185,793 - $229,326	2,278 Added 1.51%	153,048 $15.4 Million
Q4 2018 Jan 03, 2019	SELL	$79.28 - $95.27 $176,239 - $211,785	-2,223 Reduced 1.45%	150,770 $12.9 Million
Q3 2018 Oct 09, 2018	SELL	$83.5 - $93.23 $124,749 - $139,285	-1,494 Reduced 0.97%	152,993 $14 Million
Q2 2018 Jul 03, 2018	BUY	$79.9 - $89.2 $172,024 - $192,047	2,153 Added 1.41%	154,487 $13.2 Million
Q1 2018 Apr 12, 2018	SELL	$71.51 - $84.69 $183,923 - $217,822	-2,572 Reduced 1.66%	152,334 $12.7 Million
Q4 2017 Jan 03, 2018	BUY	$63.24 - $72.8 $783,353 - $901,773	12,387 Added 8.69%	154,906 $11.2 Million
Q3 2017 Oct 03, 2017	BUY	$59.73 - $65.4 $8.51 Million - $9.32 Million	142,519	142,519 $9.09 Million

Others Institutions Holding ZTS

# of Institutions

1,957

Shares Held

410M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $77.1B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neville Rodie & Shaw Inc, based on Form 13F filings with the SEC.

News

Stay updated on Neville Rodie & Shaw Inc with notifications on news.

Account

Neville Rodie & Shaw Inc Zoetis Inc. Transaction History